Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02756143
Other study ID # PERINATEXER
Secondary ID
Status Completed
Phase N/A
First received April 21, 2016
Last updated October 26, 2017
Start date November 2014
Est. completion date February 2017

Study information

Verified date October 2017
Source University Hospital of Torrejon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Effect of Physical Exercise Program on fetoplacental circulation and perinatal outcome.


Description:

The aim of this study is to examine the effect of a supervised physical exercise program during pregnancy on fetoplacental circulation, fetal heart echocardiogram parameters and perinatal outcome.


Recruitment information / eligibility

Status Completed
Enrollment 125
Est. completion date February 2017
Est. primary completion date December 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Healthy and able to exercise following American College of Obstetricians and Gynecologists (ACOG) guidelines

- Able to communicate in spanish

- Giving birth at Torrejon Universitary Hospital

Exclusion Criteria:

- Medical or obstetric complication excluding exercise ( ACOG guideline)

- Interested in the study after 18 weeks or pregnancy

- Not availability to attend to the physical exercise program

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise
Supervised physical conditioning program of three 55—60 minute sessions per week during whole pregnancy (from week 9 to 38). Each session consists of 25-30 minutes of cardiovascular exercise,10 minutes of specific exercises (strength and balance exercises), and 10 minutes of pelvic floor muscles training. Aerobic activity was prescribed at light to moderate intensity, aiming for 55-60% of heart rate reserve. All subjects wore a heart rate (HR) monitor (Polar FT7) during the training sessions to ensure that exercise intensity was light to moderate.

Locations

Country Name City State
Spain University Hospital de Torrejon Torrejon de Ardoz Madrid

Sponsors (2)

Lead Sponsor Collaborator
University Hospital of Torrejon Universidad Politecnica de Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maternal weight gain during pregnancy From the beginning of the pregnancy to 1 month postdelivery
Secondary Cesarean Section Rate Birth
Secondary Gestational Diabetes Birth
Secondary Preeclampsia birth
Secondary Fetal TAPSE Tricuspid Annular Plane Systolic Excursion meassured by echocardiogram up to 36 weeks of pregnancy
Secondary Fetal Tei Index Myocardial Performance Index meassured by echocardiogram up to 36 weeks of pregnancy
Secondary Ductus Arteriosus PI Ductus Arteriosus Pulsatility Index meassured by echocardiogram up to 36 weeks
Secondary Aortic Isthmus PI Aortic Isthmus Pulsatility Index meassured by echocardiogram up to 36 weeks
Secondary Fetal Heart Rate Variability Fetal Heart Rate Variability meassured by cardiotocogram birth
Secondary Newborn weight birth birth
Secondary Placental weight birth
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1

External Links